March 1999: adverse event reports received

1,017 reports in the openFDA release of 28 Sep 2026

Read this first · FDA's caveat, in its words

An API dataset query result cannot be used to estimate the risk associated with the product or compare one drug or device product with another. When looking at the results, be aware that there is no certainty that the reported drug or device caused the adverse event. This dataset should not be the sole source of information for clinical decision-making or other assumptions about the safety or effectiveness of a product. The adverse event may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources. FDA Center for Veterinary Medicine

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.

Not veterinary advice. This site lists what was reported to FDA. For an animal that is unwell, contact a veterinarian.

1,017reports received

283same month a year earlier+259%

807monthly average, preceding 12 months

60.6%concern dogscats 9.4%

FDA's database holds 1,017 adverse event reports received in March 1999, against 283 in the same month a year earlier and a monthly average of 807 over the preceding 12 months.

60.6% of the month's reports concern dogs, 9.4% cats and 3.2% horses; the rest concern other species, exposed people, or give no species.

By active ingredient, the drugs named most often were carprofen (312), etodolac (57) and selegiline hydrochloride (57), and the terms listed most often were death (149), accidental exposure (125) and vomiting (120). Report volume has a seasonal shape, with more reports in the warmer months when parasite products are in heavier use.

The months around it

Drugs named most often, by active ingredient

Active ingredients recorded for the drug	Reports	Share of the month's reports
Carprofen	312	30.7%
Etodolac	57	5.6%
Selegiline Hydrochloride	57	5.6%
Melengestrol Acetate	41	4%
Milbemycin Oxime	37	3.6%
Lufenuron + Milbemycin Oxime	35	3.4%
Moxidectin	35	3.4%
Tilmicosin Phosphate	30	2.9%
Eprinomectin	24	2.4%
Clomipramine Hydrochloride	18	1.8%
Lufenuron	17	1.7%
Oxytetracycline	17	1.7%
Doramectin	16	1.6%
Medetomidine	16	1.6%
Pyrantel Pamoate	14	1.4%

Ordered by report count, which follows how widely each drug was in use. FDA states that these data cannot be used to estimate risk or to compare one product with another. Brand and manufacturer names are masked by FDA in these records.

Signs listed most often

Death14.7%149
Accidental exposure[exposure that was not intended]12.3%125
Vomiting11.8%120
Anorexia[not eating]11.2%114
Depression[dull, quiet or withdrawn]9.4%96
No sign[no clinical sign was reported]9.1%93
Death by euthanasia[the animal was euthanized]6.7%68
Unclassifiable adverse event[event that fits no dictionary term]6.3%64
Diarrhoea[diarrhea]5.9%60
Elevated serum alkaline phosphatase (SAP)[a liver and bone enzyme above the normal range]5.3%54
Elevated alanine aminotransferase (ALT)[a liver enzyme above the normal range]5%51
Ineffective, heartworm larvae[legacy FDA term: the product did not have the expected effect (heartworm larvae)]4.2%43
Convulsion[seizure]3.9%40
Ineffective, estrus suppressio[legacy FDA term: the product did not have the expected effect (estrus suppressio)]3.9%40
Elevated total bilirubin[bilirubin above the normal range]3.7%38

Single ingredients, pooled

Carprofen30.7%312

Milbemycin Oxime7.1%72

Etodolac5.6%57

Selegiline Hydrochloride5.6%57

Lufenuron5.1%52

Melengestrol Acetate4%41

Moxidectin3.4%35

Tilmicosin Phosphate2.9%30

Eprinomectin2.4%24

Pyrantel Pamoate2.2%22

Clomipramine Hydrochloride1.8%18

Oxytetracycline1.8%18

Species

Dog60.6%616

Cat9.4%96

Horse3.2%33

Other or not given26.7%272

Questions about March 1999

How many animal drug adverse event reports did FDA receive in March 1999?

1,017 reports are in the openFDA release of 28 Sep 2026. The same month a year earlier has 283.

Which drugs were named most often?

By active ingredient: carprofen (312), etodolac (57), selegiline hydrochloride (57), melengestrol acetate (41) and milbemycin oxime (37). Brands are masked in the public data.

Which signs were listed most often?

death (149), accidental exposure (125), vomiting (120), anorexia (114) and depression (96).

Can the count for a month still change?

Yes. FDA posts reports quarterly with a delay of three to six months, so the newest months are incomplete and usually grow in later releases. Older months change little.

Does a busy month mean something went wrong that month?

Not by itself. The date is when FDA received the report, not when the event happened, and volume follows season, product launches and publicity. FDA states that "there is no certainty that the reported drug or device caused the adverse event" and that the event "may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources."

Where this comes from. Counts are built from the openFDA Animal & Veterinary adverse event bulk files released 28 Sep 2026, which hold reports FDA's Center for Veterinary Medicine received through 31 Mar 2026. openFDA masks brand and manufacturer names in these files, so drugs are counted by the active ingredients each record discloses and no figure is attributed to a brand, application or company. Ingredient names, and the separate reference lists of approved products, follow the FDA Green Book as of 1 Oct 2026. The month is the date FDA first received the report, not the date of the event. No report text, lot numbers or reporter details are published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.